Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 296, pseudogene (RN7SL296P) is a human pseudogene belonging to a large family of 7SL RNA-derived genetic elements. The canonical 7SL RNA is a structural non-coding RNA component of the *signal recognition particle* (SRP), which plays a critical role in targeting proteins to the endoplasmic reticulum during translation[5]. However, RN7SL296P is not a functional gene but a pseudogene—an inactivated copy or fragment produced through the reverse transcription and genomic insertion of 7SL RNA. These 7SL pseudogenes are structurally diverse and typically truncated at one or both ends of the original 7SL RNA sequence[1][3][7]. There is no evidence that RN7SL296P has a biological function, acts as a therapeutic target, or is involved in any disease processes. Most 7SL RNA pseudogenes are not transcribed or translated and are considered genomic “fossils” of retrotranspositional activity[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 296, pseudogene (RN7SL296P).